Three-dimensional printed models as an effective tool for the management of complex congenital heart disease.

3D models 3D printing congenital heart disease pediatric surgery pre-planning

Journal

Frontiers in bioengineering and biotechnology
ISSN: 2296-4185
Titre abrégé: Front Bioeng Biotechnol
Pays: Switzerland
ID NLM: 101632513

Informations de publication

Date de publication:
2024
Historique:
received: 12 01 2024
accepted: 15 07 2024
medline: 19 8 2024
pubmed: 19 8 2024
entrez: 19 8 2024
Statut: epublish

Résumé

Three-dimensional printed models are widely used in the medical field for surgical and interventional planning. In the context of complex cardiovascular defects such as pediatric congenital heart diseases (CHDs), the adoption of 3D printed models could be an effective tool to improve decision-making. In this paper, an investigation was conducted into the characteristics of 3D printed models and their added value in understanding and managing complex pediatric congenital heart disease, also considering the associated cost. Volumetric MRI and CT images of subjects with complex CHDs were retrospectively segmented, and the associated 3D models were reconstructed. Different 3D printing technologies and materials were evaluated to obtain the 3D printed models of cardiac structures. An evaluation of time and costs associated with the 3D printing procedure was also provided. A two-level 3D printed model assessment was carried out to investigate the most suitable 3D printing technology for the management of complex CHDs and the effectiveness of 3D printed models in the pre-surgical planning and surgical strategies' simulations. Among the different techniques, selective laser sintering resulted to be the most suitable due to its reduced time and cost and for the positive clinical feedback (procedure simulation, surface finish, and reproduction of details). The adoption of 3D printed models contributes as an effective tool in the management of complex CHDs, enabling planning and simulations of surgical procedures in a safer way.

Identifiants

pubmed: 39157439
doi: 10.3389/fbioe.2024.1369514
pii: 1369514
pmc: PMC11327011
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1369514

Informations de copyright

Copyright © 2024 Capellini, Ait-Ali, Pak, Cantinotti, Murzi, Vignali, Fanni, Clemente, Celi and Gasparotti.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Katia Capellini (K)

BioCardioLab, Bioengineering Unit, Fondazione Toscana Gabriele Monasterio, Massa, Italy.

Lamia Ait-Ali (L)

Institute of Clinical Physiology, CNR, Massa, Italy.

Vitali Pak (V)

Department of Pediatric Cardiac Surgery, Fondazione Toscana Gabriele Monasterio, Massa, Italy.

Massimiliano Cantinotti (M)

Department of Pediatric Cardiology, Fondazione Toscana Gabriele Monasterio, Massa, Italy.

Michele Murzi (M)

Department of Adult Cardiac Surgery, Fondazione Toscana Gabriele Monasterio, Massa, Italy.

Emanuele Vignali (E)

BioCardioLab, Bioengineering Unit, Fondazione Toscana Gabriele Monasterio, Massa, Italy.

Benigno Marco Fanni (BM)

BioCardioLab, Bioengineering Unit, Fondazione Toscana Gabriele Monasterio, Massa, Italy.

Alberto Clemente (A)

Department of Clinical Imaging, Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Simona Celi (S)

BioCardioLab, Bioengineering Unit, Fondazione Toscana Gabriele Monasterio, Massa, Italy.

Emanuele Gasparotti (E)

BioCardioLab, Bioengineering Unit, Fondazione Toscana Gabriele Monasterio, Massa, Italy.

Classifications MeSH